Originally known as Alemtuzumab Campath now Lemtrada.
How does it work?
Alemtuzumab binds to an antigen called CD52 which is found on the surface of certain T-cells, a type of lymphocyte involved in the MS immune response, and kills the T-cell.
This monoclonal antibody was licensed to treat a type of leukaemia (under the brandname MabCampath).
How is it given?
Alemtuzumab is given by intravenous infusion. In clinical trials, alemtuzumab was given as an iv infusion for 5 days and again for 3 days one year later.
Anyone who did the trials please post your experiences here along with any other useful information.
Thanks fellow MSers.
How does it work?
Alemtuzumab binds to an antigen called CD52 which is found on the surface of certain T-cells, a type of lymphocyte involved in the MS immune response, and kills the T-cell.
This monoclonal antibody was licensed to treat a type of leukaemia (under the brandname MabCampath).
How is it given?
Alemtuzumab is given by intravenous infusion. In clinical trials, alemtuzumab was given as an iv infusion for 5 days and again for 3 days one year later.
Anyone who did the trials please post your experiences here along with any other useful information.
Thanks fellow MSers.
Comment